| Course | NU 670 Advanced Psychopharmacology and Health Promotion |
|---|---|
| Unit | Unit 5 |
| Paper type | Metabolic monitoring protocol |
| Length | About 710 words, 5 pages |
| Format | APA 7 student paper |
| School | Herzing University |
| Program | MSN Psychiatric Mental Health Nurse Practitioner |
| Updated | October 2026 |
Free sample paper for NU 670 Unit 5
Metabolic Monitoring Protocol for Adults Starting a Second-Generation Antipsychotic in an Outpatient Psychiatric Clinic
Student Name
Department of Nursing, Herzing University
NU 670: Advanced Psychopharmacology and Health Promotion
Instructor Name
February 18, 2026
Metabolic Monitoring Protocol for Adults Starting a Second-Generation Antipsychotic in an Outpatient Psychiatric Clinic
Scope
Applies to: adults starting, or switching to, any second-generation antipsychotic in the composite outpatient psychiatric clinic, including olanzapine, quetiapine, risperidone, aripiprazole, and others. The schedule follows the consensus recommendations developed jointly by diabetes, psychiatric, endocrine, and obesity associations (American Diabetes Association et al., 2004), adapted to allow a glycated hemoglobin test in place of fasting glucose, which many patients find easier. Monitoring applies to every agent in the group, although the agents with the greatest metabolic effects, olanzapine and clozapine, warrant the closest attention.
What Is Measured and When
The schedule counts from the date the antipsychotic is started.
| Measure | Baseline | 4 weeks | 8 weeks | 12 weeks | Then |
|---|---|---|---|---|---|
| Personal and family history of diabetes, heart disease, and obesity | Yes | Update annually | |||
| Weight and body mass index | Yes | Yes | Yes | Yes | Every visit, at least quarterly |
| Waist circumference | Yes | Annually | |||
| Blood pressure, seated and standing | Yes | Yes | Annually, and at any visit with dizziness | ||
| Fasting glucose or glycated hemoglobin | Yes | Yes | Annually | ||
| Fasting lipid panel | Yes | Yes | Every 5 years if normal; annually if abnormal or on olanzapine or clozapine |
What Counts as a Change Worth Acting On
Weight: a gain of 5% or more of baseline body weight at any point triggers the response below; the consensus statement recommends considering a switch to another agent at this threshold (American Diabetes Association et al., 2004). A gain of 7% or more is treated as significant for reporting. Glucose: a glycated hemoglobin of 5.7% to 6.4%, or fasting glucose of 100 to 125 mg/dL, is recorded as prediabetes; 6.5% or 126 mg/dL or higher, confirmed, as diabetes. Lipids: triglycerides of 150 mg/dL or higher or LDL cholesterol above the patient's target triggers referral. Blood pressure: 130/80 or higher on two visits, or a standing drop of 20 mm Hg systolic, triggers review.
The Response Ladder
Step 1, any weight gain or new abnormal value: discuss with the patient at the same visit, record in the problem list, and offer referral to the clinic's nutrition group or dietitian.
Step 2, weight gain of 5% or more, or prediabetes: review the need for the current agent; consider switching to an agent with lower metabolic risk if psychiatric stability allows; consider adding metformin, which a meta-analysis found reduced antipsychotic-induced weight gain compared with placebo (de Silva et al., 2016); and notify the primary care clinician.
Step 3, diabetes or significant dyslipidemia: refer to primary care for treatment in a documented handoff; continue the antipsychotic decision with the patient, weighing psychiatric benefit against metabolic harm.
Who Sees the Results, and Who Acts
The prescriber orders the tests and reviews each result within one week. Results are shared with the patient at the next visit, in plain language. Every abnormal result is sent to the patient's primary care clinician with a note stating what the psychiatric clinic will do and what it asks primary care to do; for patients without a primary care clinician, the clinic's care coordinator arranges one. The clinic nurse maintains a monitoring registry that flags patients whose next measurement is overdue.
Why the Registry Matters
Recommendations are not the problem; completion is. A systematic review of screening practices found that routine metabolic monitoring of people taking antipsychotics was often incomplete, with lipid and glucose testing done for a minority of patients in many settings (Mitchell et al., 2012). The registry exists because a schedule that depends on each prescriber remembering will not be followed reliably. Each month, the nurse reviews the registry, contacts patients who are overdue, and reports the percentage of patients up to date on each measure to the clinic's quality meeting.
Talking With the Patient About Monitoring
Before the first dose, the prescriber explains why the measurements are taken: that the medication can increase appetite and change how the body handles sugar and fat, that these changes are effects of the drug rather than personal failings, and that catching them early gives more options, including switching or adding a medication that limits weight gain. Patients are given a card showing the schedule and their baseline values, so they can see their own trend. Framed this way, monitoring becomes something done with the patient rather than to them, and patients are more likely to return for the 4- and 8-week weight checks, which are the ones most often missed.
Special Situations
Patients switching agents restart the schedule from the switch date. Patients who smoke and plan to quit, particularly on olanzapine or clozapine, have weight and blood pressure rechecked one to two weeks after quitting, since drug levels may rise. Patients who cannot fast have glycated hemoglobin and a non-fasting lipid panel instead.
References
American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, & North American Association for the Study of Obesity. (2004). Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care, 27(2), 596-601. https://doi.org/10.2337/diacare.27.2.596
de Silva, V. A., Suraweera, C., Ratnatunga, S. S., Dayabandara, M., Wanniarachchi, N., & Hanwella, R. (2016). Metformin in prevention and treatment of antipsychotic induced weight gain: A systematic review and meta-analysis. BMC Psychiatry, 16, Article 341. https://doi.org/10.1186/s12888-016-1049-5
Mitchell, A. J., Delaffon, V., Vancampfort, D., Correll, C. U., & De Hert, M. (2012). Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: Systematic review and meta-analysis of screening practices. Psychological Medicine, 42(1), 125-147. https://doi.org/10.1017/S003329171100105X
Reading the NU 670 Unit 5 instructions
Unit 5 asks you to write a metabolic monitoring protocol for patients on antipsychotic medication. Expect to define scope, set measurements and intervals, define thresholds for action, describe a stepped response, assign responsibilities, address completion and patient communication and cover special situations. Many versions ask you to follow the ADA and APA consensus statement. Check whether your section wants metabolic monitoring only or other parameters too. The gap in practice is completion, not knowledge, so explain how the clinic will make sure monitoring happens. Thresholds should come from guidelines. A response ladder tells the clinician what to do at each level, which is more useful than a list of tests. Include how results reach primary care.
Inside the NU 670 Unit 5 example
The protocol opens with scope: which patients and which agents. A table gives the schedule from baseline through annual checks. The thresholds section defines changes worth acting on, each with its source. The response ladder moves from the least to the most intensive step, including lifestyle referral and metformin. The responsibilities section names who orders, reviews and acts. The registry section explains that completion is the real problem and describes how the clinic will track it. The patient section gives wording for explaining monitoring before the first dose. Special situations cover switching agents and smoking changes. Each element cites the consensus statement or the evidence base, so the protocol rests on more than local habit.
Reading the NU 670 Unit 5 rubric
Herzing's rubric for a monitoring protocol generally covers scope, the schedule, thresholds, the response plan, responsibilities, completion strategies, patient communication and writing. The schedule and thresholds are checked against the consensus statement, so intervals and cutoffs should match it. Response plan points reward a stepped approach tied to thresholds. Responsibility criteria look for named roles. Completion strategies often separate stronger protocols, because the rubric recognizes that monitoring fails in practice. Patient communication earns credit for plain explanations. The ADA and APA consensus statement and Mitchell's review of screening practices belong in the APA 7 list. Coordination with primary care, including who manages a new diabetes diagnosis, is sometimes its own line. Special situations, such as switching agents or a patient who quits smoking on olanzapine, earn credit when the protocol says exactly what restarts.
NU 670 Unit 5 help: mistakes that cost points
Monitoring protocols in Unit 5 commonly lose points through a schedule without thresholds or actions. Another frequent problem is intervals that do not match the consensus statement. Students often leave out who is responsible for each step. Completion is assumed. Metformin and other evidence-based responses are missing from the ladder. Patient communication is left out. Coordination with primary care is ignored. Finally, explain how the clinic will know monitoring happened, because graders recognize that the main gap in practice is incomplete monitoring, and a protocol without a tracking method repeats that gap on paper. Waist circumference is another common omission, though the consensus statement includes it at baseline and yearly.
Get a NU 670 Unit 5 example written to your instructions
Send the Unit 5 instructions and the rubric from your NU 670 classroom, naming the agent group the schedule has to cover. We write a custom example with baseline established first, parameters ordered by how early they move, intervals attached one by one, thresholds written as triggers and a reader named for each result. First custom sample free, back in 24 to 48 hours.
More NU 670 papers and PMHNP samples
- NU 670 Unit 1: Receptor activity brief
- NU 670 Unit 2: Clearance pathway table
- NU 670 Unit 3: Whole regimen interaction screen
- NU 670 Unit 4: Adverse effect derivation record
- NU 670 Unit 6: Special population handling brief
- NU 670 Unit 7: Lifestyle and psychoeducation package
- NU 670 Unit 8: Regimen lifecycle dossier
- NU 671 Unit 5: Diagnostic criteria mapping
- NU 672 Unit 5: Group therapy proposal
- NU 673 Unit 5: Medication and cognition review
- NU 674 Unit 5: Civil commitment statute analysis
NU 670 Unit 5 questions, answered
How specific should the intervals be?
Specific enough to be entered in a schedule, and sourced. Name the guidance you are following, its year, and the population it addresses, then express intervals as a relation to starting rather than as fixed dates. Recommendations differ between bodies and get revised, so the protocol is written to be checked against the current version rather than trusted on its own account.
Does the protocol cover metabolic parameters only?
It covers whatever the agent group obliges, which for some products includes counts, levels or a registry operating under its own rules. Where a mandatory program governs an agent, describe that it exists and what a compliant record contains, and treat its current requirements as something to verify with the program itself rather than reproduce from memory.
What if a clinic cannot run all of it?
Say so inside the protocol rather than outside it. A schedule demanding more than a setting can deliver gets abandoned quietly and completely, whereas one naming the minimum set and the order in which additions would come survives contact with a real clinic. Instructors generally credit the constrained version, provided the reasoning for what stayed and what waited is written down.
Where can I find a free NU 670 Unit 5 sample paper?
You can read the whole NU 670 Unit 5 monitoring protocol here for free, the schedule, thresholds, response ladder and registry. A protocol for a clinic with fewer resources or other parameters can be written on request.
How often should metabolic labs be checked on antipsychotics?
The ADA and APA consensus statement recommends baseline measures, weight at 4, 8 and 12 weeks, glucose and lipids at 12 weeks, then periodic checks, with glucose yearly. This sample builds that schedule into a clinic protocol with thresholds and actions.